Showing results (11-20 of 360) with videos related to
Sort By:
Pageof 36
Hospital Practice (Office Ed.)|August 1, 1989
Optimal thrombolytic therapy: for whom, when, howJ L AndersonJournal of the American College of Cardiology|November 1, 1987
Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agentJ L AndersonClinical Therapeutics|January 1, 1985
Bretylium tosylate: profile of the only available class III antiarrhythmic agentJ L AndersonClinical Therapeutics|January 1, 1985
Conventional and sustained-release procainamide: update on pharmacology and clinical useJ L AndersonJournal of Clinical Pharmacology|November 1, 1990
Reassessment of benefit-risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac arrhythmia suppression trialJ L AndersonThe American Journal of Cardiology|August 20, 1992
Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia InvestigatorsJ L AndersonClinical Therapeutics|January 1, 1984
Current understanding of lidocaine as an antiarrhythmic agent: a reviewJ L AndersonLife Sciences|April 18, 1983
Serotonin receptor changes after chronic antidepressant treatments: ligand binding, electrophysiological, and behavioral studiesJ L AndersonThe American Journal of Cardiology|July 30, 1984
Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapyJ L AndersonPageof 36